fluconazole has been researched along with Cystitis in 5 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Cystitis: Inflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful urination (dysuria), increased frequency, urgency, and suprapubic pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| " krusei breakthrough infections was similar to what is seen with high-dose fluconazole (400 mg) prophylaxis, and no adverse effects of low-dose fluconazole in terms of increased incidence of non-susceptible Candida species was seen." | 5.31 | Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome. ( Henslee-Downey, JP; Mehta, J; Safdar, A; Singhal, S; van Rhee, F, 2001) |
| "Fluconazole was administered orally (7." | 1.31 | Aspergillus species cystitis in a cat. ( Adamama-Moraitou, KK; Paitaki, CG; Rallis, TS; Tontis, D, 2001) |
| " krusei breakthrough infections was similar to what is seen with high-dose fluconazole (400 mg) prophylaxis, and no adverse effects of low-dose fluconazole in terms of increased incidence of non-susceptible Candida species was seen." | 1.31 | Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome. ( Henslee-Downey, JP; Mehta, J; Safdar, A; Singhal, S; van Rhee, F, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capilla-Miranda, A | 1 |
| Plaza-López, D | 1 |
| Garcia-Clemente, P | 1 |
| Baquero-Artigao, F | 1 |
| Etienne, M | 1 |
| Caron, F | 1 |
| Adamama-Moraitou, KK | 1 |
| Paitaki, CG | 1 |
| Rallis, TS | 1 |
| Tontis, D | 1 |
| Safdar, A | 1 |
| van Rhee, F | 1 |
| Henslee-Downey, JP | 1 |
| Singhal, S | 1 |
| Mehta, J | 1 |
| Bergami, G | 1 |
| Di Mario, M | 1 |
| Barbuti, D | 1 |
| Cozza, R | 1 |
1 review available for fluconazole and Cystitis
| Article | Year |
|---|---|
[Management of fungal urinary tract infections].
Topics: Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Cystitis; D | 2007 |
4 other studies available for fluconazole and Cystitis
| Article | Year |
|---|---|
Intermittent bladder irrigation with liposomal amphotericin B for the treatment of fluconazole-resistant Meyerozyma guilliermondii cystitis in an immunosuppressed adolescent.
Topics: Adolescent; Cystitis; Fluconazole; Humans; Urinary Bladder | 2023 |
Aspergillus species cystitis in a cat.
Topics: Animals; Antibodies, Fungal; Antifungal Agents; Aspergillus nidulans; Cat Diseases; Cats; Cystitis; | 2001 |
Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Topics: Adolescent; Adult; Antifungal Agents; Bacteremia; Bone Marrow Transplantation; Candida; Candidiasis; | 2001 |
[The echographic diagnosis of Candida albicans cystitis in childhood].
Topics: Candidiasis; Child; Cystitis; Dysgerminoma; Female; Fluconazole; Humans; Opportunistic Infections; S | 1991 |